scholarly journals A Very Rare Reason for Gastric Perforation, Caused by Gastric Metastasis of Breast Cancer: Case Presentation

2019 ◽  
Vol 15 (1) ◽  
pp. 59-62 ◽  
Author(s):  
Sertac Ata Guler ◽  
◽  
Turgay Simsek ◽  
Gokhan Posteki ◽  
Alican Guresin ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Gastric Perforation ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Gastric Metastasis ◽  
Case Presentation

scholarly journals Subtrochanteric Fracture as First Sign of Metastatic Breast Cancer: Case Presentation

2015 ◽  
Vol 6 (8) ◽  
pp. 367-372
Author(s):  
Bogdan Deleanu ◽  
Radu Prejbeanu ◽  
Dan Crisan ◽  
Dinu Vermesan ◽  
Vlad Predescu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Breast Cancer Case ◽  
Subtrochanteric Fracture ◽  
Cancer Case ◽  
Case Presentation

THERAPEUTICAL SURGICAL CHOICES FOR BILATERAL BREAST CANCER- CASE PRESENTATION

2003 ◽  
Vol 13 (Suppl 1) ◽  
pp. 88.1-88
Author(s):  
P. C. Bratila ◽  
O. Nicodin ◽  
N. Niculescu ◽  
M. Serban ◽  
E. Raducea Barbulea ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bilateral Breast Cancer ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Case Presentation ◽  
Surgical Choices

Occult breast cancer: Case report and literature revision

2020 ◽  
Author(s):  
Inês Morais Rodrigues ◽  
Fernando Igreja ◽  
Isabel Riscado ◽  
Rosa Madureira ◽  
Ana Nobre Pinto
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Occult Breast Cancer

Effectiveness of combination with eribulin in third line of chemotherapy for triple negative breast cancer (case report)

2021 ◽  
Vol 1 (31) ◽  
pp. 20-24
Author(s):  
M. V. Kalugin ◽  
K. A. Ivanova ◽  
E. I. Borisova ◽  
S. S. Nakhapetyan ◽  
S. L. Gutorov
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Metastatic Breast ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Antitumor Action ◽  
Illustrative Case ◽  
Development Of Resistance ◽  
Triple Negative Phenotype

In most cases triple negative breast cancer is characterized by an aggressive course of disease and early development of resistance to chemotherapy. Thereafter, the late-line treatment choice, usually after anthracyclines and taxanes, is problematic due to the limited amount of effective and low-toxic cytostatics. In our opinion, in this situation the use of eribulin which possesses unique antitumor action mechanisms is a good option. An illustrative case of a pronounced antitumor effect of eribulin in metastatic breast cancer with triple negative phenotype resistant to previous lines of chemotherapy is presented.

scholarly journals Bilateral atrophic squirrhus of breast in neglected breast cancer: case report

2014 ◽  
Vol 19 ◽  
Author(s):  
Doulira Louati ◽  
Khaled Trigui ◽  
Donia Abid ◽  
Salma Kammoun ◽  
Manel Dermech ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Breast Cancer Case ◽  
Cancer Case

Ectopic Breast Cancer: Case Report and Review of the Literature

2013 ◽  
Vol 37 (4) ◽  
pp. 746-749 ◽  
Author(s):  
Elisa Francone ◽  
Marco J. Nathan ◽  
Federica Murelli ◽  
Maria Santina Bruno ◽  
Enrico Traverso ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Review Of The Literature ◽  
Ectopic Breast

scholarly journals HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature

Breast Care ◽  
2016 ◽  
Vol 11 (6) ◽  
pp. 424-426 ◽  
Author(s):  
Arpine Gevorgyan ◽  
Giacomo Bregni ◽  
Giulia Galli ◽  
Elisa Zanardi ◽  
Filippo de Braud ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Case Report ◽  
Targeted Therapy ◽  
Neuroendocrine Carcinoma ◽  
Immunohistochemical Analysis ◽  
Breast Cancer Case ◽  
Cancer Case ◽  
Review Of Literature ◽  
Her2 Amplification ◽  
Her2 Positive

Background: Neuroendocrine carcinoma is an uncommon histology for breast cancer. Case Report: Our patient underwent right quadrantectomy for a neuroendocrine carcinoma in 1984 and had a bone relapse 30 years later. After thorough pathological and immunohistochemical analysis the diagnosis was confirmed and HER2 amplification was observed. Here we discuss the management, rationale and results of HER2-targeted therapy in advanced neuroendocrine breast carcinoma.

Sign in / Sign up

Export Citation Format

Share Document